Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/PA/Scranton
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Scranton, PA

Studies commonly pay $75 to $4,500 per completed study

98 clinical trials are currently recruiting participants within 30 miles of Scranton. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

98studies recruiting
5+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Scranton right now

Top 25 of 98 recruiting studies, sorted by proximity — each links to its official registry page

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: SWOG Cancer Research Network

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

Cancer N/A Interventional 500 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: Eastern Cooperative Oncology Group

A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

Lyme Disease Phase 3 Interventional 1,712 participants sought
Northeast Clinical Trials Group — Scranton, Pennsylvania (0.3 mi) · Sponsor: Pfizer

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Metastatic Breast Cancer Phase 3 Interventional 500 participants sought
Capital Health Hematology Oncology Specialists — Newton, Pennsylvania (17.3 mi) · Sponsor: American Society of Clinical Oncology

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Treatment Resistant Depression N/A Interventional 6,800 participants sought
Scranton Medical Institutes — Moosic, Pennsylvania (5.2 mi) · Sponsor: LivaNova

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: SWOG Cancer Research Network

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: SWOG Cancer Research Network

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

Lymphoma, Malignant Solid Neoplasm Phase 3 Interventional 668 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: University of Rochester

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,500 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: NRG Oncology

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: Canadian Cancer Trials Group

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration, nAMD Phase 3 Interventional 304 participants sought
Eye Care Specialists - Kingston — Kingston, Pennsylvania (15.6 mi) · Sponsor: Amgen

Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding

GastroIntestinal Bleeding N/A Observational 3,000 participants sought
The Wright Center for Graduate Medical Education, 501 S. Washington Avenue — Scranton, Pennsylvania (0.3 mi) · Sponsor: Xingshun Qi

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: National Cancer Institute (NCI)

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Phase 3 Interventional 1,978 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: National Cancer Institute (NCI)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: Medtronic

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma Phase 3 Interventional 269 participants sought
Northeast Radiation Oncology Center — Dunmore, Pennsylvania (2.0 mi) · Sponsor: NRG Oncology

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: SWOG Cancer Research Network

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation N/A Observational 538 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: PrECOG, LLC.
Actively enrolling

Studies you may be able to join near Scranton

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Scranton

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Northeast Clinical Trials Group (NECTR)

★ 5.0
802 Jefferson Ave, Scranton, PA 18510
(570) 504-5507

Altasciences

★ 4.2
130 Discovery Dr, Scott, PA 18447
(800) 300-8114

Lehigh Center for Clinical Research

★ 5.0
1245 S Cedar Crest Blvd, Allentown, PA 18103
(610) 820-0342
"Staff was very friendly and explained information to me in great detail"
— Virgilio Baello, 5★

Velocity Clinical Research

★ 4.5
4100 Vestal Rd Ste LL-100, Vestal, NY 13850
(607) 794-5790
"I've been waiting a week for them to pay me and I bet they're not even going to compensate me for the inconvenience of their ignorance. My old lady 6…"
— Obee Mcspanky, 2★

Geisinger Precision Health Center

★ 5.0
190 Welles St, Forty Fort, PA 18704
(570) 714-6420

Clinical trials in Scranton: what's recruiting

The Scranton area currently has 98 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Scranton, the most active research areas are:

  • Cancer & Oncology18 studies
  • Heart & Vascular3 studies
  • Brain & Mental Health1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Scranton, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Scranton

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Scranton participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Scranton pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Scranton, PA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Scranton?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Scranton typically complete one or two studies per year.

Paid clinical trials near Scranton

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of PA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts